Delivery Order SPE2DR25D3012-SPE2DR26F4F2B
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,567.58 to AmerisourceBergen Drug Corp for the supply of Posaconazole DR 100 mg tablets (60-count). This competitive award, issued on September 16, 2025, with an ultimate completion date of September 17, 2025, utilizes firm fixed pricing and carries no set-aside designation. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate headquarters....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 2, 2025, for the supply of Posaconazole DR 100 mg tablets (60-count units) with a ceiling value of $1,199.24. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was made through open competition. The contract is set to complete by December 3, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a $9,298.99 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Posaconazole DR 100 mg tablets in unit-dose packaging of 20s. This contract, which represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, was competitively awarded with no set-aside designation and is scheduled for completion by September 10, 2025. The product will be delivered to...
- The Defense Logistics Agency awarded a $1,972.34 delivery order to AmerisourceBergen Drug Corp for Posaconazole 300 mg/16.7 ml vials on December 30, 2025, with a completion date of December 31, 2025. This firm fixed-price contract, which is not set-aside, represents a competitively awarded procurement supporting federal pharmaceutical supply requirements. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for Posaconazole 300 mg/16.7 ml vials valued at $3,190.66 on December 22, 2025, with completion expected by December 23, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and represents a pharmaceutical supply transaction supporting federal medical procurement needs. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania,...
- The Defense Logistics Agency awarded a delivery order valued at $2,626.20 to AmerisourceBergen Drug Corp for Posaconazole 300 mg/16.7 ml vials on December 29, 2025, with an ultimate completion date of December 30, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Posaconazole is an antifungal medication commonly used in military and federal healthcare systems...
- The Defense Logistics Agency awarded a delivery order valued at $6,875.75 to AmerisourceBergen Drug Corp for the supply of Posaconazole 300 mg/16.7 ml vials on January 5, 2026, with an ultimate completion date of January 6, 2026. This competitive, non-set-aside contract utilizes firm fixed pricing and is performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,056.58 to AmerisourceBergen Drug Corp for the supply of Posaconazole 300 mg/16.7 mL vials on December 11, 2025, with an ultimate completion date of December 12, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a single delivery order under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $2,055.80 firm fixed price delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Posaconazole 300 mg/16.7 ml vials. The contract, with an ultimate completion date of July 21, 2025, represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX and valued at $999.999 billion through December 2026. This award carries no set-aside...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Posaconazole 200 mg/5 mL suspension (105 mL) valued at $9,864.11 on July 24, 2025, with completion scheduled for July 25, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the vendor's Corporate Office location in Conshohocken, Pennsylvania. The contract represents a single pharmaceutical delivery under the DLA's medical supply...
- SPE2DR25D3012Indefinite Delivery Contract
- SPE2DR25D3012-SPE2DR26F4F2BDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,155.39 to AmerisourceBergen Drug Corp for Posaconazole DR 100 MG tablets in unit dose packaging of 20s. This contract, awarded on January 16, 2026, with an ultimate completion date of January 20, 2026, utilizes a firm fixed-price structure with no set-aside designation, indicating competitive award. The place of performance is Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate office. This delivery order is issued under AmerisourceBergen Drug Corp's parent company, Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical valued at $999,999,999.00 through December 31, 2031. That comprehensive IDC serves as the primary vehicle for supplying a broad range of pharmaceutical products and medical supplies to support military healthcare programs globally, including specialty medications, brand-name and generic drugs, vaccines, and related medical commodities. The current task order for Posaconazole, an antifungal medication commonly used in military and veteran healthcare settings, exemplifies the routine pharmaceutical procurement conducted under this strategic contract vehicle.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 1/15/26 |